Literature DB >> 33887658

Possible contribution of cerebellar disinhibition in epilepsy.

Xue Ming1, Nithisha Prasad2, Venkatraman Thulasi3, Kathryn Elkins4, Veeresh Kumar N Shivamurthy5.   

Abstract

OBJECTIVE: We hypothesize that loss of inhibition from the cerebellum can lead to cortical activation and seizures.
BACKGROUND: The traditional model for development of seizures purports that the source of seizures is increased electrical activity originating from cerebral cortical neurons. Studies have shown a decrease in inhibition results in a shift of cortical activity to a hyperexcitable state, which may lead to seizures. Interestingly, a 1978 study suggested the term "disorder of disinhibition" as a way to describe epilepsy from studies of chronic cerebellar stimulation. DESIGN/
METHODS: Cases and experimental studies in which cerebellar lesions have been implicated in the development of seizures were reviewed. Cases in which cerebellar inhibition has been targeted in the treatment of seizures were also included. Twenty-six studies and case reports are presented for this report.
RESULTS: The cases show cerebellar lesions can lead to cortical epileptiform activity. Purkinje cell loss is linked to the occurrence of seizures in animals. The majority of patients with cerebellar lesions were seizure free after complete resection, while less than half of patients were seizure free after partial resection. Novel treatments using deep-brain stimulation targeting cerebellar structures demonstrated therapeutic benefits for seizures.
CONCLUSIONS: Although pathophysiology is not well-understood, the cerebellum likely plays an inherent role in inhibiting aberrant cortical epileptogenesis. Cerebellar lesions may cause seizures due to loss of the inhibition of cortical areas or through intrinsic epileptic activity. Treatments enhancing cerebellar stimulation have shown therapeutic benefits in treating seizures, which could potentially provide another avenue for treatment.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebellum; Epilepsy; Hippocampus; Purkinje; Seizure

Mesh:

Year:  2021        PMID: 33887658     DOI: 10.1016/j.yebeh.2021.107944

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation.

Authors:  Marion Coolen; Nami Altin; Karthyayani Rajamani; Eva Pereira; Karine Siquier-Pernet; Emilia Puig Lombardi; Nadjeda Moreno; Giulia Barcia; Marianne Yvert; Annie Laquerrière; Aurore Pouliet; Patrick Nitschké; Nathalie Boddaert; Antonio Rausell; Féréchté Razavi; Alexandra Afenjar; Thierry Billette de Villemeur; Almundher Al-Maawali; Khalid Al-Thihli; Julia Baptista; Ana Beleza-Meireles; Catherine Garel; Marine Legendre; Antoinette Gelot; Lydie Burglen; Sébastien Moutton; Vincent Cantagrel
Journal:  Am J Hum Genet       Date:  2022-04-06       Impact factor: 11.043

2.  Seizures and Postictal Psychosis in a Patient With Retrocerebellar Arachnoid Cyst: A Case Report.

Authors:  Rittika Biswas; Ishan Sen
Journal:  Cureus       Date:  2022-05-12

3.  Controlling absence seizures from the cerebellar nuclei via activation of the Gq signaling pathway.

Authors:  Jan Claudius Schwitalla; Johanna Pakusch; Brix Mücher; Alexander Brückner; Dominic Alexej Depke; Thomas Fenzl; Chris I De Zeeuw; Lieke Kros; Freek E Hoebeek; Melanie D Mark
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.207

Review 4.  Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom.

Authors:  Leonardo R Ancheta; Patrick A Shramm; Raschel Bouajram; Denise Higgins; Douglas A Lappi
Journal:  Toxins (Basel)       Date:  2022-03-02       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.